Drug
Eos100850
Eos100850: highest development phase Phase 1, developed by iTeos Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- iTeos Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| EOS100850 NCT03873883 | Phase 1 | Solid Tumor, Adult |
Latest
No recent events.
Follow Eos100850 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.